These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 24935464)

  • 1. Utilization of glucose, blood pressure, and lipid lowering medications among people with type II diabetes in the United States, 1999-2010.
    Wong HK; Ong KL; Cheung CL; Cheung BM
    Ann Epidemiol; 2014 Jul; 24(7):516-21.e1. PubMed ID: 24935464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999-2008.
    Kuznik A; Mardekian J
    Cardiovasc Diabetol; 2011 Apr; 10():31. PubMed ID: 21496321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National survey: Evaluation of cardiovascular risk factors in Thai patients with type 2 diabetes and chronic kidney disease after the development of cardiovascular disease.
    Changsirikulchai S; Sangthawan P; Janma J; Sripaiboonkij N; Rattanamongkolgul S; Thinkhamrop B
    Nephrology (Carlton); 2018 Jan; 23(1):53-59. PubMed ID: 27608176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood pressure and lipid management fall far short in persons with type 2 diabetes: results from the DIAB-CORE Consortium including six German population-based studies.
    Rückert IM; Schunk M; Holle R; Schipf S; Völzke H; Kluttig A; Greiser KH; Berger K; Müller G; Ellert U; Neuhauser H; Rathmann W; Tamayo T; Moebus S; Andrich S; Meisinger C
    Cardiovasc Diabetol; 2012 May; 11():50. PubMed ID: 22569118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing diabetes care regarding cardiovascular targets at general practice level: Direct@GP.
    Wens J; Gerard R; Vandenberghe H
    Prim Care Diabetes; 2011 Apr; 5(1):19-24. PubMed ID: 21030327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Undetected dysglycaemia common in primary care patients treated for hypertension and/or dyslipidaemia: on the need for a screening strategy in clinical practice. A report from EUROASPIRE IV a registry from the EuroObservational Research Programme of the European Society of Cardiology.
    Shahim B; Gyberg V; De Bacquer D; Kotseva K; De Backer G; Schnell O; Tuomilehto J; Wood D; Rydén L
    Cardiovasc Diabetol; 2018 Jan; 17(1):21. PubMed ID: 29368616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological management of modifiable cardiovascular risk factors (blood pressure and lipids) following diagnosis of myocardial infarction, stroke and diabetes: comparison between population-based studies in Russia and Norway.
    Cook S; Hopstock LA; Eggen AE; Bates K; Iakunchykova O; Kontsevaya A; McKee M; Schirmer H; Voevoda M; Kudryavtsev AV; Malyutina S; Leon DA
    BMC Cardiovasc Disord; 2020 May; 20(1):234. PubMed ID: 32430002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Messages from the Malaysian Diabetes Registries on Diabetes Care in Malaysian public healthcare facilities.
    Chew BH; Lee PY; Cheong AT; Ismail M; Shariff-Ghazali S; Goh PP
    Prim Care Diabetes; 2016 Oct; 10(5):383-6. PubMed ID: 27459893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Prevalence, Awareness, Treatment, and Control of Cardiovascular Risk Factors in China and the United States.
    Lu Y; Wang P; Zhou T; Lu J; Spatz ES; Nasir K; Jiang L; Krumholz HM
    J Am Heart Assoc; 2018 Jan; 7(3):. PubMed ID: 29374046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Change in cardiovascular risk factors in relation to diabetes status: the Tromso Study.
    Joseph J; Svartberg J; Njølstad I; Schirmer H
    Eur J Prev Cardiol; 2012 Jun; 19(3):551-7. PubMed ID: 21505026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality associated with less intense risk-factor control among adults with diabetes in the United States.
    Saydah SH; Gregg EW; Kahn HS; Ali MK
    Prim Care Diabetes; 2018 Feb; 12(1):3-12. PubMed ID: 28797537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in the Prescription of Glucose-Lowering Medications in Patients With Type 2 Diabetes Mellitus After a Cardiovascular Event: A Call to Action From the DATAFILE Study.
    Fadini GP; Frison V; Simioni N; Lapolla A; Gatti A; Bossi AC; Del Buono A; Fornengo P; Gottardo L; Laudato M; Perseghin G; Bonora E; Avogaro A
    J Am Heart Assoc; 2019 Jul; 8(14):e012244. PubMed ID: 31269877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Achievement of recommended glucose and blood pressure targets in patients with type 2 diabetes and hypertension in clinical practice - study rationale and protocol of DIALOGUE.
    Gitt AK; Schmieder RE; Duetting E; Bramlage P; Schneider S; Tschöpe D;
    Cardiovasc Diabetol; 2012 Dec; 11():148. PubMed ID: 23216660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of co-morbid mental illness on the diagnosis and management of patients hospitalized for medical conditions in a general hospital.
    Briskman I; Bar G; Boaz M; Shargorodsky M
    Int J Psychiatry Med; 2012; 43(4):339-48. PubMed ID: 23094466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study.
    Yurgin N; Secnik K; Lage MJ
    Clin Ther; 2007 Feb; 29(2):316-25. PubMed ID: 17472823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Socioeconomic position and cardiovascular risk factors among people with screen-detected Type 2 DM: six-year follow-up of the ADDITION-Denmark trial.
    Dalsgaard EM; Vestergaard M; Skriver MV; Borch-Johnsen K; Lauritzen T; Sandbaek A
    Prim Care Diabetes; 2014 Dec; 8(4):322-9. PubMed ID: 24613817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular risk management in type 2 diabetes of more than 10-year duration: Results of Polish ARETAEUS2-Grupa Study.
    Leśniak W; Bała MM; Płaczkiewicz-Jankowska E; Topór-Mądry R; Jankowski M; Sieradzki J; Banasiak W;
    Cardiol J; 2015; 22(2):150-9. PubMed ID: 25299503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perceptions of Canadian Vascular Surgeons Toward Pharmacologic Risk Reduction in Patients with Peripheral Artery Disease: 2018 Update.
    Li B; Salata K; de Mestral C; Hussain MA; Aljabri BA; Lindsay TF; Verma S; Al-Omran M
    Ann Vasc Surg; 2019 Jul; 58():166-173.e4. PubMed ID: 30771465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of glycemia and blood pressure in British adults with diabetes mellitus and subsequent therapy choices: a comparison across health states.
    McAlister FA; Lethebe BC; Lambe C; Williamson T; Lowerison M
    Cardiovasc Diabetol; 2018 Feb; 17(1):27. PubMed ID: 29433515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalised treatment targets in type 2 diabetes patients: The Dutch approach.
    Boels AM; Hart HE; Rutten GE; Vos RC
    Prim Care Diabetes; 2017 Feb; 11(1):71-77. PubMed ID: 27633894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.